Pharmacyclics Inc. (PCYC) reported second quarter adjusted EPS of $0.62 after the close Thursday, down from $0.82 in the prior year period. The consensus estimate was for EPS of $0.29.
Pharmacyclics rose steadily during the first half of Friday's session and closed up by 6.79 at $87.00 on above average volume. The stock rose to its third consecutive new high for the year.
For comments and feedback: editorial@rttnews.com